Equities research analysts at JPMorgan Chase & Co. assumed coverage on shares of Informa (LON:INF - Get Free Report) in a note issued to investors on Tuesday, MarketBeat Ratings reports. The firm set an "overweight" rating and a GBX 1,020 ($13.47) price target on the stock. JPMorgan Chase & Co.'s price objective suggests a potential upside of 18.22% from the company's previous close.
Separately, Shore Capital restated a "buy" rating and set a GBX 930 ($12.29) target price on shares of Informa in a report on Friday, May 23rd.
Get Our Latest Analysis on Informa
Informa Stock Down 0.6%
Shares of Informa stock traded down GBX 5.40 ($0.07) on Tuesday, hitting GBX 862.80 ($11.40). The company had a trading volume of 6,913,714 shares, compared to its average volume of 11,103,395. The firm has a market capitalization of £11.36 billion, a P/E ratio of 37.15, a P/E/G ratio of 0.75 and a beta of 1.12. Informa has a twelve month low of GBX 634.20 ($8.38) and a twelve month high of GBX 911.60 ($12.04). The company has a debt-to-equity ratio of 31.98, a current ratio of 0.56 and a quick ratio of 1.70. The stock has a 50-day moving average of GBX 815.93 and a 200-day moving average of GBX 798.58.
Informa (LON:INF - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The company reported GBX 30.10 ($0.40) EPS for the quarter. Informa had a net margin of 9.30% and a return on equity of 4.75%. Research analysts predict that Informa will post 59.3240265 earnings per share for the current year.
Insider Buying and Selling
In other Informa news, insider Stephen A. Carter sold 406,936 shares of the stock in a transaction on Tuesday, July 29th. The shares were sold at an average price of GBX 865 ($11.43), for a total value of £3,519,996.40 ($4,649,929.19). 0.53% of the stock is currently owned by corporate insiders.
Informa Company Profile
(
Get Free Report)
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
Featured Stories
Before you consider Informa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Informa wasn't on the list.
While Informa currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.